{"id":538426,"date":"2021-09-15T07:33:26","date_gmt":"2021-09-15T11:33:26","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/heat-biologics-ceo-to-present-at-the-cantor-fitzgerald-global-healthcare-conference-on-september-29th\/"},"modified":"2021-09-15T07:33:26","modified_gmt":"2021-09-15T11:33:26","slug":"heat-biologics-ceo-to-present-at-the-cantor-fitzgerald-global-healthcare-conference-on-september-29th","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/heat-biologics-ceo-to-present-at-the-cantor-fitzgerald-global-healthcare-conference-on-september-29th\/","title":{"rendered":"Heat Biologics CEO to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29th"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">DURHAM, N.C., Sept.  15, 2021  (GLOBE NEWSWIRE) &#8212; Heat Biologics, Inc. (Nasdaq: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today announced that Jeff Wolf, Chief Executive Officer of Heat Biologics, will be presenting at the Cantor Fitzgerald Global Healthcare Conference being held virtually between September 27-30, 2021.<\/p>\n<p align=\"justify\">\n        <strong>Presentation Details:<\/strong><br \/>\n        <br \/>Date: Wednesday, September 29, 2021<br \/>Time: 9:20 AM ET \/ 6:20 AM PT<br \/>Webcast: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OpATveDhy0c490bY3Tf7s5GRDMxvNZMayZK7ZkPOVuNZjS2K9QLxESTUU1SWrqfbAQLvrDkeT0y25kFYhDcZdvZiUPaLaGK6FAn76Crt97j7aW1QSXtzlLMe6IL1NzByVjsVedHiRCiRvr-IJ8cALPZIPiCmyp6e4xEGhNxOMxXPzGetixfGn6eISIO9s6HNarTLLybvMKRfsaXu2zc-ezRKEBrqRX0QoisAlt4vFr5XEwjhzcLIjpQ8Kwhkbkl_\" rel=\"nofollow noopener\" target=\"_blank\">Cantor Global Healthcare Conference<\/a><\/p>\n<p align=\"justify\">\n        <strong>About Heat Biologics, Inc.<\/strong><br \/>\n        <br \/>Heat Biologics is a biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system. Heat\u2019s gp96 platform is designed to activate immune responses against cancer or infectious diseases. The Company has multiple product candidates in development leveraging the gp96 platform, including HS-110, which has completed enrollment in a Phase 2 trial, various infectious disease\/biological threat programs in preclinical development and a pipeline of proprietary immunomodulatory antibodies and cell-based therapies, including PTX-35 and HS-130 in Phase 1 clinical trials.<\/p>\n<p align=\"justify\">For more information, please visit:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=y9GSt_-Ty_b3iMpv_Xgy7EkNZJIJ9O-5FAdqz_u-DynGQxijIMxamZSAJwWg7qUZDiKIsh3eTSDkaebzjcVXEGaSsDzBQRSYFuBjvgR0gZPjTk5FxWDBOGny4AaR23bBCmksN2s28m-rdoLNzCogJLZeGjempOOJYymgPVHIXoKb-2g-H4y2ahqbApOQv08DCpSmPSMXlp8_lkMJ9c-Af1FPNY0eGfbrndQldeddYD8=\" rel=\"nofollow noopener\" target=\"_blank\">www.heatbio.com<\/a>, and also follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=bviwnN8nXX8-cmNG4f8laZvBSeZBYstT58KFQ7KJX6yGJ5RRftZw1PXtqyO4eedl8mGxXE3keK3-yJ1C5Ha4iv7TaySW6jx28LWtiSLb4-0icwEO781oLeB59F8nL48s489OOxDha_dHiaWtTeRey3clqDvVny5L1unwqpTRH8haCtDohqlFsMKEzfqNJ7KENP9dZRauump7Z0PEkf6AtQ==\" rel=\"nofollow noopener\" target=\"_blank\">Twitter<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Media and Investor Relations Contact<\/strong><br \/>\n        <br \/>David Waldman<br \/>+1 919 289 4017<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3V6vFXTWS38504pgL3QdzOUHrTjy7gVyCJ2u_kWzPQj0yyMnPTHLEfIIYz9f5RzL0XGuT9Nn4H8OeG-JTAZqSv0m1go7NzWWtH8o8WWGQuZdEPoIWTRvzTL3XDpp6TL2\" rel=\"nofollow noopener\" target=\"_blank\"><u>investorrelations@heatbio.com<\/u><\/a><\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNDY1NyM0NDAxNzE5IzIwMjg0MjY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ZTcyMmVlMTQtYTUyMS00NjBmLThmNTMtNGQ3OGY1NDEyNjAyLTEwMzg0Mjc=\/tiny\/Heat-Biologics.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>DURHAM, N.C., Sept. 15, 2021 (GLOBE NEWSWIRE) &#8212; Heat Biologics, Inc. (Nasdaq: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today announced that Jeff Wolf, Chief Executive Officer of Heat Biologics, will be presenting at the Cantor Fitzgerald Global Healthcare Conference being held virtually between September 27-30, 2021. Presentation Details: Date: Wednesday, September 29, 2021Time: 9:20 AM ET \/ 6:20 AM PTWebcast: Cantor Global Healthcare Conference About Heat Biologics, Inc. Heat Biologics is a biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system. Heat\u2019s gp96 platform is designed to activate immune responses against cancer or infectious diseases. The Company has multiple product candidates in development leveraging the gp96 platform, including &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/heat-biologics-ceo-to-present-at-the-cantor-fitzgerald-global-healthcare-conference-on-september-29th\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Heat Biologics CEO to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29th&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-538426","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Heat Biologics CEO to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29th - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/heat-biologics-ceo-to-present-at-the-cantor-fitzgerald-global-healthcare-conference-on-september-29th\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Heat Biologics CEO to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29th - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"DURHAM, N.C., Sept. 15, 2021 (GLOBE NEWSWIRE) &#8212; Heat Biologics, Inc. (Nasdaq: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today announced that Jeff Wolf, Chief Executive Officer of Heat Biologics, will be presenting at the Cantor Fitzgerald Global Healthcare Conference being held virtually between September 27-30, 2021. Presentation Details: Date: Wednesday, September 29, 2021Time: 9:20 AM ET \/ 6:20 AM PTWebcast: Cantor Global Healthcare Conference About Heat Biologics, Inc. Heat Biologics is a biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system. Heat\u2019s gp96 platform is designed to activate immune responses against cancer or infectious diseases. The Company has multiple product candidates in development leveraging the gp96 platform, including &hellip; Continue reading &quot;Heat Biologics CEO to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29th&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/heat-biologics-ceo-to-present-at-the-cantor-fitzgerald-global-healthcare-conference-on-september-29th\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-15T11:33:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNDY1NyM0NDAxNzE5IzIwMjg0MjY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/heat-biologics-ceo-to-present-at-the-cantor-fitzgerald-global-healthcare-conference-on-september-29th\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/heat-biologics-ceo-to-present-at-the-cantor-fitzgerald-global-healthcare-conference-on-september-29th\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Heat Biologics CEO to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29th\",\"datePublished\":\"2021-09-15T11:33:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/heat-biologics-ceo-to-present-at-the-cantor-fitzgerald-global-healthcare-conference-on-september-29th\\\/\"},\"wordCount\":190,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/heat-biologics-ceo-to-present-at-the-cantor-fitzgerald-global-healthcare-conference-on-september-29th\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyNDY1NyM0NDAxNzE5IzIwMjg0MjY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/heat-biologics-ceo-to-present-at-the-cantor-fitzgerald-global-healthcare-conference-on-september-29th\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/heat-biologics-ceo-to-present-at-the-cantor-fitzgerald-global-healthcare-conference-on-september-29th\\\/\",\"name\":\"Heat Biologics CEO to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29th - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/heat-biologics-ceo-to-present-at-the-cantor-fitzgerald-global-healthcare-conference-on-september-29th\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/heat-biologics-ceo-to-present-at-the-cantor-fitzgerald-global-healthcare-conference-on-september-29th\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyNDY1NyM0NDAxNzE5IzIwMjg0MjY=\",\"datePublished\":\"2021-09-15T11:33:26+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/heat-biologics-ceo-to-present-at-the-cantor-fitzgerald-global-healthcare-conference-on-september-29th\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/heat-biologics-ceo-to-present-at-the-cantor-fitzgerald-global-healthcare-conference-on-september-29th\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/heat-biologics-ceo-to-present-at-the-cantor-fitzgerald-global-healthcare-conference-on-september-29th\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyNDY1NyM0NDAxNzE5IzIwMjg0MjY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyNDY1NyM0NDAxNzE5IzIwMjg0MjY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/heat-biologics-ceo-to-present-at-the-cantor-fitzgerald-global-healthcare-conference-on-september-29th\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Heat Biologics CEO to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29th\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Heat Biologics CEO to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29th - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/heat-biologics-ceo-to-present-at-the-cantor-fitzgerald-global-healthcare-conference-on-september-29th\/","og_locale":"en_US","og_type":"article","og_title":"Heat Biologics CEO to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29th - Market Newsdesk","og_description":"DURHAM, N.C., Sept. 15, 2021 (GLOBE NEWSWIRE) &#8212; Heat Biologics, Inc. (Nasdaq: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today announced that Jeff Wolf, Chief Executive Officer of Heat Biologics, will be presenting at the Cantor Fitzgerald Global Healthcare Conference being held virtually between September 27-30, 2021. Presentation Details: Date: Wednesday, September 29, 2021Time: 9:20 AM ET \/ 6:20 AM PTWebcast: Cantor Global Healthcare Conference About Heat Biologics, Inc. Heat Biologics is a biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system. Heat\u2019s gp96 platform is designed to activate immune responses against cancer or infectious diseases. The Company has multiple product candidates in development leveraging the gp96 platform, including &hellip; Continue reading \"Heat Biologics CEO to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29th\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/heat-biologics-ceo-to-present-at-the-cantor-fitzgerald-global-healthcare-conference-on-september-29th\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-15T11:33:26+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNDY1NyM0NDAxNzE5IzIwMjg0MjY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/heat-biologics-ceo-to-present-at-the-cantor-fitzgerald-global-healthcare-conference-on-september-29th\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/heat-biologics-ceo-to-present-at-the-cantor-fitzgerald-global-healthcare-conference-on-september-29th\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Heat Biologics CEO to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29th","datePublished":"2021-09-15T11:33:26+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/heat-biologics-ceo-to-present-at-the-cantor-fitzgerald-global-healthcare-conference-on-september-29th\/"},"wordCount":190,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/heat-biologics-ceo-to-present-at-the-cantor-fitzgerald-global-healthcare-conference-on-september-29th\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNDY1NyM0NDAxNzE5IzIwMjg0MjY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/heat-biologics-ceo-to-present-at-the-cantor-fitzgerald-global-healthcare-conference-on-september-29th\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/heat-biologics-ceo-to-present-at-the-cantor-fitzgerald-global-healthcare-conference-on-september-29th\/","name":"Heat Biologics CEO to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29th - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/heat-biologics-ceo-to-present-at-the-cantor-fitzgerald-global-healthcare-conference-on-september-29th\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/heat-biologics-ceo-to-present-at-the-cantor-fitzgerald-global-healthcare-conference-on-september-29th\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNDY1NyM0NDAxNzE5IzIwMjg0MjY=","datePublished":"2021-09-15T11:33:26+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/heat-biologics-ceo-to-present-at-the-cantor-fitzgerald-global-healthcare-conference-on-september-29th\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/heat-biologics-ceo-to-present-at-the-cantor-fitzgerald-global-healthcare-conference-on-september-29th\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/heat-biologics-ceo-to-present-at-the-cantor-fitzgerald-global-healthcare-conference-on-september-29th\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNDY1NyM0NDAxNzE5IzIwMjg0MjY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNDY1NyM0NDAxNzE5IzIwMjg0MjY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/heat-biologics-ceo-to-present-at-the-cantor-fitzgerald-global-healthcare-conference-on-september-29th\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Heat Biologics CEO to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29th"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/538426","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=538426"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/538426\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=538426"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=538426"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=538426"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}